ArticleEnvironment & health (Washington, D.C.)2026
Desalination of Seawater: Comprehensive Nontarget Assessment of Disinfection Byproducts.
Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Disinfection Byproducts in Desalinated Water: Identifying Toxicity Drivers through Nontarget Analysis.Environment & health (Washington, D.C.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to growing populations and water scarcity, desalination is increasingly used to generate safe drinking water. A concern is the potential formation of more toxic brominated and iodinated disinfection byproducts (DBPs) in the finished drinking water. While desalination technologies remove much of the organic matter and bromide/iodide precursors to DBP formation, lower molecular weight, uncharged compounds and salts are not completely removed. We present a comprehensive nontarget identification of DBPs from desalination, using a broadscreen, comprehensive approach with gas chromatography (GC)-high resolution-mass spectrometry (MS) to identify DBPs produced in desalinated waters treated with chlorine, chlorine dioxide, ozone, chloramine, and UV. We include real desalinated waters from three large desalination plants in the United Arab Emirates, along with controlled laboratory treatments of these waters, allowing a direct comparison of different disinfectants. Mammalian cell cytotoxicity analyses for new desalination DBPs are also reported, along with whole-water toxicology for treated desalinated waters. Fifty-five DBPs were identified, including many reported for the first time in desalinated water, including a new dibromomethyl-pyrazole, along with haloketones, haloaldehydes, halonitromethanes, haloamides, and >2 carbon haloacids. Di- and tribromophenols had greater cytotoxicity compared to corresponding regulated di- and trihaloacetic acids. Reverse osmosis (RO)-treated waters had higher cytotoxicity than distilled waters (multistage flash and multieffect distillation). Of the RO-treated waters, samples treated with ozone-chlorine had highest cytotoxicity, followed by UV, ozone, and chloramine, consistent with increased formation of more toxic bromonitromethanes and dibromoacetic acid with ozone-chlorine. However, DBP levels in the treated desalinated waters and whole-water cytotoxicity were lower than found in typical drinking waters, suggesting that, despite increased formation of brominated DBPs, desalination may produce safer water overall.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.